Sign in
BIOS Stock Price, Chart, Stats & News
BioPlus Acquisition Corp.
Save
209.07M
Market cap
51.40x
Current P/E
–
Forward P/E
BIOS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -158.67% |
ROA | 2.17% |
ROE | 2.33% |
D/E | 0.02x |
Interest coverage ratio | – |
BIOS valuation
P/E | 51.40x |
P/S | – |
P/B | 28.94x |
P/CF | -9332.60x |
P/FCF | -302.36x |
P/OCF | -9332.60x |
PEG | 12.50x |
EV multiple | -174.39x |
About
Currently, BioPlus Acquisition Corp. possesses no major active business operations. Its express mandate is to pursue and complete a strategic combination, which may take the form of a merger, share exchange, asset purchase, stock acquisition, reorganization, or similar transaction. This targeted consolidation is specifically aimed at one or more entities within the vibrant life sciences industry.
Similar securities
Based on sector and market capitalization
Report issue